CoSo Health to work with U.S. Endovascular and others to reach the U.S. market DENVER, May 30, 2023 /PRNewswire/ — CoSo Health today announced signing a U.S. distribution agreement with Medinol for EluNIR™, a new generation, thin-strut drug-eluting stent (DES). Medinol is a global leader in the development of innovative implantable medical devices. U.S. Endovascular sells peripheral […]